COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02562118
Recruitment Status : Unknown
Verified May 2016 by National University Hospital, Singapore.
Recruitment status was:  Recruiting
First Posted : September 29, 2015
Last Update Posted : June 1, 2016
Eisai Co., Ltd.
Information provided by (Responsible Party):
National University Hospital, Singapore